What is the role of molecular markers in CNS tumor classification?
In recent updates to the WHO classification, molecular markers have become increasingly important. These markers can provide critical information about the tumor's biology and potential response to treatment. For example, the presence of IDH mutations in gliomas is associated with a better prognosis. Similarly, 1p/19q co-deletion in oligodendrogliomas indicates a favorable response to chemotherapy and radiation.
